Hospira Inc. has announced a $120-million investment in its McPherson, Kansas, facility for capital improvements at the site during the next five years. As part of the McPherson investment, Hospira will be completing capital improvement and modernization projects, including expanding capacity, adding automated visual inspection systems, and installing additional production lines at the facility.

The McPherson plant has approximately 1,400 employees and produces generic injectable and biologic medicines using advanced manufacturing technology, including lyophilization, isolator-filling lines and aseptic filling processes. The McPherson facility provides medications in multiple delivery systems, including glass vials, ampuls, syringes, and cartridges, and makes products for One 2 One, Hospira’s pharmaceutical contract manufacturing business.

Source: Kansas Department of Commerce